BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34234400)

  • 1. Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control.
    Lam PY; Chow SC; Lam WC; Chow LLW; Fung NSK
    Clin Ophthalmol; 2021; 15():2767-2785. PubMed ID: 34234400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital - A Tertiary Referral Center.
    Preechasuk L; Tantasuwan S; Likitmaskul S; Santiprabhob J; Lertbannaphong O; Plengvidhya N; Tangjittipokin W; Nitiyanant W; Lertwattanarak R
    Diabetes Metab Syndr Obes; 2022; 15():1375-1387. PubMed ID: 35528720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials.
    Sun S; Hisland L; Grenet G; Gueyffier F; Cornu C; Jaafari N; Boussageon R
    Therapie; 2022; 77(4):413-423. PubMed ID: 34782145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative diabetic retinopathy as the initial presenting feature of type 1 diabetes.
    Ranathunga I; Idampitiya C
    Endocrinol Diabetes Metab Case Rep; 2023 Oct; 2023(4):. PubMed ID: 38108392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.
    Davis MD; Beck RW; Home PD; Sandow J; Ferris FL
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):240-3. PubMed ID: 17479440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control and diabetic retinopathy.
    Rodriguez-Fontal M; Kerrison JB; Alfaro DV; Jablon EP
    Curr Diabetes Rev; 2009 Feb; 5(1):3-7. PubMed ID: 19199891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review.
    Akil H; Burgess J; Nevitt S; Harding SP; Alam U; Burgess P
    Diabetes Ther; 2022 Jan; 13(1):1-23. PubMed ID: 34928488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on diabetic retinopathy.
    Aiello LM
    Am J Ophthalmol; 2003 Jul; 136(1):122-35. PubMed ID: 12834680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaanalysis of the effects of intensive glycemic control on late complications of type I diabetes mellitus.
    Wang PH; Lau J; Chalmers TC
    Online J Curr Clin Trials; 1993 May; Doc No 60():[5023 words; 37 paragraphs]. PubMed ID: 8306007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology and natural history of diabetic retinopathy: an overview.
    Morello CM
    Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S3-7. PubMed ID: 17720892
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.